Exposure to natalizumab during pregnancy and lactation is safe - No.
作者信息
Airas Laura
机构信息
Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland; Department of Clinical Medicine, University of Turku, Turku, Finland/Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.
出版信息
Mult Scler. 2020 Jul;26(8):889-891. doi: 10.1177/1352458520917934. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
Exposure to natalizumab during pregnancy and lactation is safe - No.孕期和哺乳期使用那他珠单抗是安全的——否。
Mult Scler. 2020 Jul;26(8):889-891. doi: 10.1177/1352458520917934. Epub 2020 Jun 8.
2
Exposure to natalizumab during pregnancy and lactation is safe - Yes.孕期及哺乳期使用那他珠单抗是安全的——是的。
Mult Scler. 2020 Jul;26(8):887-889. doi: 10.1177/1352458520915814. Epub 2020 Jun 8.
3
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder.多发性硬化症或视神经脊髓炎谱系疾病女性患者在妊娠和/或哺乳期使用单克隆抗体治疗。
Neurol Neuroimmunol Neuroinflamm. 2020 Apr 23;7(4). doi: 10.1212/NXI.0000000000000723. Print 2020 Jul 2.
4
Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.多发性硬化症患者孕期使用那他珠单抗的系统评价
J Neurol Sci. 2019 Jan 15;396:202-205. doi: 10.1016/j.jns.2018.11.026. Epub 2018 Nov 22.
5
Natalizumab during pregnancy and lactation.那他珠单抗在妊娠和哺乳期的应用。
Mult Scler. 2018 Oct;24(12):1627-1634. doi: 10.1177/1352458517728813. Epub 2017 Aug 31.
6
How safe is natalizumab during pregnancy?那他珠单抗在孕期的安全性如何？
Mult Scler. 2015 Feb;21(2):121-2. doi: 10.1177/1352458514555789. Epub 2014 Nov 12.
7
[Disease modifying drugs in multiple sclerosis and pregnancy].[多发性硬化症的疾病修饰药物与妊娠]
Med Clin (Barc). 2012 Sep 22;139(7):316-8. doi: 10.1016/j.medcli.2012.04.021. Epub 2012 Jun 27.
8
Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use.孕期使用natalizumab 的多发性硬化症女性的妊娠结局。
Mult Scler Relat Disord. 2020 May;40:101961. doi: 10.1016/j.msard.2020.101961. Epub 2020 Jan 30.
9
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.多发性硬化症女性患者在使用那他珠单抗治疗后的妊娠决策：II：母体风险。
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
10
Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases.使用那他珠单抗治疗多发性硬化后生育健康婴儿：两例报告。
Acta Neurol Scand. 2011 Jun;123(6):430-3. doi: 10.1111/j.1600-0404.2010.01426.x. Epub 2010 Sep 16.
引用本文的文献
1
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series.疾病修饰疗法与血液系统疾病：病例报告和病例系列的系统评价
Front Neurol. 2024 Jun 18;15:1386527. doi: 10.3389/fneur.2024.1386527. eCollection 2024.
2
Adverse Obstetric Outcomes in Pregnant Women Using Natalizumab for the Treatment of Multiple Sclerosis: A Systematic Review.使用那他珠单抗治疗多发性硬化症的孕妇的不良产科结局：一项系统评价
Cureus. 2022 Oct 5;14(10):e29952. doi: 10.7759/cureus.29952. eCollection 2022 Oct.
3
Natalizumab treatment during pregnancy in multiple sclerosis-clinical and bioethical aspects of an ongoing debate.孕期使用那他珠单抗治疗多发性硬化症——持续争论的临床和生物伦理学方面。
Wien Med Wochenschr. 2022 Nov;172(15-16):373-378. doi: 10.1007/s10354-022-00913-6. Epub 2022 Feb 10.
4
Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.妊娠对多发性硬化症的影响及疾病修饰疗法的作用
Front Neurol. 2021 Jul 1;12:697974. doi: 10.3389/fneur.2021.697974. eCollection 2021.
5
Susac syndrome and pregnancy: a review of published cases and considerations for patient management.Susac综合征与妊娠：已发表病例综述及患者管理考量
Ther Adv Neurol Disord. 2021 Jan 30;14:1756286420981352. doi: 10.1177/1756286420981352. eCollection 2021.
本文引用的文献
1
Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity.妊娠中的免疫适应调节类风湿关节炎疾病活动。
Nat Rev Rheumatol. 2020 Feb;16(2):113-122. doi: 10.1038/s41584-019-0351-2. Epub 2020 Jan 13.
2
Humoral response to John Cunningham virus during pregnancy in multiple sclerosis.妊娠期间多发性硬化症对约翰·坎宁安病毒的体液反应。
Mult Scler Relat Disord. 2018 Apr;21:11-18. doi: 10.1016/j.msard.2018.02.008. Epub 2018 Feb 9.
3
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.多发性硬化症女性患者在使用那他珠单抗治疗后的妊娠决策：II：母体风险。
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
4
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.从泰萨比®（那他珠单抗）妊娠暴露登记处评估妊娠结局：一项全球观察性随访研究。
BMC Neurol. 2016 Aug 24;16(1):150. doi: 10.1186/s12883-016-0674-4.
5
Transfer of natalizumab into breast milk in a mother with multiple sclerosis.一名患有多发性硬化症的母亲体内那他珠单抗向母乳中的转移情况。
J Hum Lact. 2015 May;31(2):233-6. doi: 10.1177/0890334414566237. Epub 2015 Jan 13.
6
Natalizumab use during the third trimester of pregnancy.妊娠晚期使用那他珠单抗。
JAMA Neurol. 2014 Jul 1;71(7):891-5. doi: 10.1001/jamaneurol.2014.209.
7
Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.免疫抑制程度轻微或隐匿的个体中的进行性多灶性白质脑病。
J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):247-54. doi: 10.1136/jnnp.2009.187666. Epub 2009 Oct 14.
8
Effects of VLA-4 antagonists in rat whole embryo culture.VLA - 4拮抗剂在大鼠全胚胎培养中的作用。
Teratology. 2002 Jan;65(1):26-37. doi: 10.1002/tera.1095.
9
Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development.由α4整合素介导的细胞黏附事件在胎盘和心脏发育中至关重要。
Development. 1995 Feb;121(2):549-60. doi: 10.1242/dev.121.2.549.
10
Expanding roles for alpha 4 integrin and its ligands in development.α4整合素及其配体在发育过程中的作用不断扩展。
Cell Adhes Commun. 1994 Apr;2(1):27-43. doi: 10.3109/15419069409014200.
Zotero 插件